N/A
N=326
The Learning Curve of NBI With Magnification in the Diagnosis of Colorectal Lesions
Colorectal Lesion
Bottom Line
View on ClinicalTrials.gov: NCT01431703 ↗Enrolled (actual)
326
Serious AEs
0.0%
Results posted
Mar 2017
Primary outcome: Primary: Accuracy, Sensitivity, and Specificity for Differentiating Neoplastic and Non-neoplastic Lesions — 94.3; 98.0; 92.0 percentage of lesions
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Pediatric, Adult, Older Adult · 16+ yrs
- Sex
- All
- Sponsor
- Zhizheng Ge
- Primary completion
- Apr 2011
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Accuracy, Sensitivity, and Specificity for Differentiating Neoplastic and Non-neoplastic Lesions |
94.3; 98.0; 92.0 | — |
Summary
It exists a learning curve in using NBI with magnification to differentiating colorectal lesions.
Eligibility Criteria
Inclusion Criteria
- Ages 16 to 85
- Any patient undergoing NBI with magnification colonoscopy exam and found with colorectal lesions
Exclusion Criteria
- Unwilling to consent
- Had surgery of colorectal tumors
- Using NSAIDS
- Diagnosed or suspected IBD
- Familial adenomatous polyposis(FAP) or hereditary non-polyposis colorectal(HNPCC) or other hereditary disease
Data sourced from ClinicalTrials.gov (NCT01431703). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.